参考资料:
[1]https://doi.org/10.1164/rccm.201302-0388PP
[2]doi/10.1111/j.1365-2222.1982.tb01641.x
[3]何志,韩玉.2009-2017年某三级综合性医院茶碱类药物使用分析[J].中国医院统计,2020,27(1):40-42.DOI:10.3969/j.issn.1006-5253.2020.01.007.
[4]张新超,邓颖,商德亚.急性心力衰竭中国急诊管理指南(2022)[J].中华急诊医学杂志,2022,31(8):1016-1041.
[5]Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, et al. 2018 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila). 2019 Dec. 57 (12):1220-1413.
[6]https://goldcopd.org/2023-gold-report-2/
[7]Devereux G, Cotton S, Fielding S, et al. Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial. JAMA 2018; 320(15): 1548-59.
[8]Jenkins CR, Wen FQ, Martin A, et al. The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial. Eur Respir J 2021; 57(6).
[9]https://ginasthma.org/2023-gina-main-report/
[10]Henriksen DP, Davidsen JR, Laursen CB. Nationwide use of theophylline among adults-A 20-year Danish drug utilisation study. Respir Med. 2018;140:57-62. doi:10.1016/j.rmed.2018.05.015
[11]敖曼,卢蕾,熊怡.氨茶碱联合抗菌药物应用致肌肉震颤1例报道[J].现代医药卫生,2017,33(6):955-956.
[12]Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706-1717. doi:10.1016/S0140-6736(18)30841-9
[13]Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study [J]. Lancet, 2019, 394(10196):407-418. DOI:10.1016/S0140-6736(19)31147-X.
[14]季琦.社区卫生服务中心住院患者平喘药物的用药分析[J].上海医药,2016,37(18):23-25.
联系客服